COVID-19: Three Indian vaccines in different phases of clinical testing, says ICMR

0
145

At present country has three Indian vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) on Tuesday.

“At the present moment, we have three Indian vaccines which are in different phases of clinical testing. The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine,” said Dr Balram Bhargava, DG, ICMR while addressing a press conference here.

“Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites,” he added.Dr Bhargava, however, said that social distancing and proper hygiene are the best “vaccine” available now and even after.

“Physical Distancing, wearing a mask, proper hand hygiene are the best vaccine available at the moment and even after. We will have to continue with these measures,” he said.

Rajesh Bhushan, Secretary, Health Ministry said the actual caseload of in the country today is 5,86,298 as more than 1.2 million people have already recovered.

India witnessed a single-day spike of 52,050 cases as the total count of cases in the country reached 18,55,746 on Tuesday.

The number of cured/discharged/migrated patients stands at 12,30,510 and 38,938 persons have died, the Health Ministry added.

 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies   


The Dispatch Staff